Buscar
Lineage Cell Therapeutics Inc
LCTXAñadir a la lista de seguimiento
1.010USD
-0.020-1.94%
Cierre 09-21 16:00（ET）
256.70MCap. mercado
PérdidaP/E TTM
Rendimiento de ingresos de Lineage Cell Therapeutics Inc (LCTX)
Actualizado: 31 de dic de 2025Por región
Ingresos operativos
Proporción
Anual
Anual
Trimestral
United States
Israel
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
United States
14.56M(100.00%)
9.50M(100.00%)
8.95M(100.00%)
14.70M(100.00%)
3.90M(89.73%)
1.16M(63.53%)
2.09M(59.52%)
1.80M(36.17%)
1.65M(47.74%)
4.50M(75.92%)
5.98M(84.93%)
3.59M(68.39%)
2.11M(47.50%)
2.53M(64.61%)
3.06M(69.01%)
Israel
--(--)
--(--)
--(--)
--(--)
446.00K(10.27%)
666.00K(36.47%)
1.42M(40.48%)
3.18M(63.83%)
1.81M(52.26%)
1.43M(24.08%)
1.06M(15.07%)
1.66M(31.61%)
2.33M(52.50%)
1.39M(35.39%)
1.37M(30.99%)